Medical Cannabis and Cannabinoids
About this Journal
Journal Metrics
| CiteScore: 6.3 | |
| Time to first decision: 33 days | |
| Time to final decision: 9 weeks |
News & Highlights
Now Indexed in PubMed
We are proud to announce that our open access journal Medical Cannabis and Cannabinoids is now indexed in PubMed Central (PMC).
New Tool for Evaluating Potential Drug-Drug Interactions Based on Cannabinoids
CANNabinoid Drug Interaction Review (CANN-DIR®), developed at Penn State College of Medicine, is intended to evaluate for potential drug-drug interactions based on the cannabinoids (THC & CBD) affecting the metabolism of OTHER concomitantly prescribed medications. This tool has been developed for use by healthcare providers, patients, caregivers, and interested community members.
Medical Cannabis and Cannabinoids has published a product review on this tool: “CANNabinoid Drug Interaction Review (CANN-DIR™)” [1], utilizing research published in the review “Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions”, appearing earlier in the journal [2].
